In Safety warnings, alerts and recalls

Enter a keyword or phrase to search all pages in this section:


Advanced search

Archive:

Looking for a previously published document in this section?

Co-proxamol

Following a 12-week exercise to gather further information on the risks and benefits of the painkiller co-proxamol, UK Ministers decided in January 2005 to accept the advice of the Committee on Safety of Medicines (CSM) that co-proxamol should be withdrawn from the market over a period of time. The following documents have been issued:

› Letter to healthcare professionals - 31 January 2005
› Questions and answers - July 2005
› Outcome of the public request for information on the risks and benefits of co-proxamol - January 2005
› Advice on analgesic options in treatment of mild to moderate pain in adults - January 2005
› Advice from the CSM Expert Working Group on analgesic options in treatment of mild to moderate pain - January 2005
› Withdrawal of co-proxamol: Reminder to prescribers - March 2006
› Position on the sale and supply of co-proxamol following cancellation of the marketing authorisations (MAs) at the end 2007 - 14 December 2007 

 

Page last modified: 27 September 2005